this week

List

August 27th, 2012

Buy Cipro No Prescription

[This review was originally posted at the Nieman Journalism Lab Buy Cipro No Prescription, on July 9, 2012.]

Journatic and new directions for local news: The hyperlocal news content provider Journatic got caught last week using fake bylines, prompting a discussion about the value and perils of outsourced journalism. Journatic provides hyperlocal content to a variety of publications (especially newspapers) through a network of freelancers. Those freelancers are often not in the area (or even the country) they're writing about, and as a This American Life piece revealed, some of them have also been using fake bylines. Cipro use, At Poynter, Anna Tarkov has the full story of how the Journatic sausage gets made, and Jim Romenesko got responses from Journatic's CEO and the TAL story's producer and main subject.

The Chicago Tribune just outsourced its hyperlocal TribLocal sections to Journatic, and it began investigating Journatic's work for fake bylines. The Chicago Sun-Times, Houston Chronicle, and San Francisco Chronicle also reported fake bylines on Journatic stories in their papers, and the Sun-Times and the newspaper chain GateHouse ended their contracts with Journatic, though GigaOM's Mathew Ingram reported that those contracts expired before the fake-byline story came out, Buy Cipro No Prescription. Journatic's CEO sent a memo rallying the troops and declaring that its aliases would be discontinued, Cipro from canadian pharmacy. By the end of the week, NPR's David Folkenflik summarized the situation and the larger conflict in how to

The revelations pointed toward a larger discussion over how to do the tough work of making local journalism sustainable, summarized well by NPR's David Folkenflik. Northeastern j-prof Dan Kennedy said operations like Journatic's "pink slime journalism" are a function of the fact that local journalism is difficult and expensive to do well, Cipro schedule, though the solution will ultimately come from the bottom up, not from cookie-cutter approaches like this. Free Press, meanwhile, urged us to demand better out of local news. Buy Cipro No Prescription, But others saw outsourced local journalism (though without fake bylines, of course) as a viable part of the future of news: Mathew Ingram also made the point that local journalism is expensive and said centralized and automated news production has to be part of the answer. John Bethune of B2B Memes said the real problem at Journatic was that it was skeuomorphic — trying to make a new form (algorithmic and outsourced content) look like an old one (articles with bylines). "The Journatic screw-up was not a failure of new media, Cipro steet value, but a failure of nerve. New-media practitioners need to have the courage of their convictions, and look, not back, Cipro samples, but steadfastly ahead." Ingram echoed that point, urging an open mind toward Journatic in a follow-up post, and Kennedy responded that "not everything new should be embraced."

—

Twitter tightens its grip: In a pair of simultaneous posts, Twitter broke off its content-syncing partnership with LinkedIn and served notice to other Twitter third-party developers that the company wouldn't be standing for apps that they feel closely mimic the "core Twitter consumption experience" on their own apps and website. All Things D's Mike Isaac said that it makes sense for Twitter to tighten the reins on its service now that it's growing and wondered how it might affect other partners such as Flipboard. Talking Points Memo's Carl Franzen asked the same thing about several companies whose services are based predominantly or exclusively on Twitter, Cipro from canada.

The Next Web's Matthew Panzarino talked to developers who called Twitter's post "ominous" and suggested the reason Twitter seems to be clamping down on its famously open development system is that it wants to control its advertising stream, Buy Cipro No Prescription. The New York Times' Nick Bilton, meanwhile, pointed out that the core user experience Twitter wants to protect isn't consistent at all between its website and various apps. BuzzFeed's Matt Buchanan said Twitter wants to make all those user experiences consistent, Purchase Cipro for sale, as well as simpler and more dynamic — and in order to do that, it needs total control of the experience.

GigaOM's Mathew Ingram issued a warning to Twitter, noting that it's upset its developer community before, and similar moves have backfired for MySpace and Digg. Tech entrepreneur Dalton Caldwell lamented the fact that Twitter hadn't chosen an API-centric route years ago, buy Cipro online cod, and Ingram explored the question of whether a media company such as Twitter could be both an open platform and a destination.

In another post Buy Cipro No Prescription, , Ingram looked at the feasibility of an open alternative to Twitter, concluding that it would be technically possible, but not likely to draw Twitter's critical mass of users. "In the end, many users don’t really seem to care whether a system or network is open or not — or at least not enough of them to make a difference," he wrote.

Another key piece of this puzzle came at about the same time, when the Wall Street Journal reported that Twitter is finding success selling ads for mobile devices, a platform that has frustrated Facebook and Google's advertising teams. Cipro online cod, The Financial Times likewise reported that Twitter has shifted to a truly mobile-first mindset, and Business Insider's Pascal-Emmanuel Gobry argued that that mobile-first nature, along with the fact that Twitter has the same ads on desktop and mobile, bodes well for Twitter's mobile business.

—

The future of News Corp.'s papers: We're continuing to see the repercussions from News Corp.'s decision two weeks ago to split into two separate news and entertainment media companies. The Wall Street Journal gave the details of the decision, buy Cipro from mexico, and David Carr of The New York Times explained why Rupert Murdoch had agreed to make the deal — his papers, with the exception of Dow Jones' Wall Street Journal, are declining quickly, and "his long-running romance with print will no longer be indulged just because he’s the boss."

The Times' Amy Chozick noted that the Murdochs are still firmly in control of the two companies (much to the annoyance of some investors), Where can i buy cheapest Cipro online, Peter Jukes of The Daily Beast said the split will hasten the end of the Murdoch dynasty. And though Murdoch praised the potential of his newspapers, The Times reported that without him directly heading the papers up, they're in a particularly vulnerable spot, Buy Cipro No Prescription. Forbes' Jeff Bercovici said the Journal will be well preserved as the company's crown jewel, but the outlook is much worse for the New York Post. The Daily Beast's Alex Klein expected the Journal to be remade in the image of its business news rival, Bloomberg.

Reuters' Felix Salmon focused on the TV side, buy Cipro without prescription, arguing that TV news is more part of the entertainment industry than the news industry, and that print media is converging on the one thing it does well — live breaking news coverage. Ad Age's Jeanine Poggi wondered whether other conglomerates like Time Warner will also spin off their print properties.

—

CNN's error and process journalism: Media observers also spent some time last week talking about CNN and Fox News' Supreme Court reporting error Buy Cipro No Prescription, , wondering why it happened and what that might mean about the state of news. Poynter's Steve Myers pinned the blame on "process journalism, Buy cheap Cipro no rx, " the philosophy of publishing stories as you piece them together and updating them with corrections. Myers said process journalism makes more sense in breaking news stories, not "appointment" stories like a Supreme Court decision. In a response, process journalism advocate Jeff Jarvis said this wasn't really process journalism, and "The real lesson here is that the scoop is and always has been a dangerous act of journalistic narcissism."

GigaOM's Mathew Ingram agreed with Jarvis on the diminishing value of the scoop and the idea that this wasn't process journalism, discount Cipro, and the Washington Post's Alexandra Petri also said this piece of news wasn't worth a scoop. Mike Masnick of Techdirt argued that this error shouldn't be cited as an indictment of the real-time news era. Poynter's Craig Silverman broke down the error in a bit more detail, attributing it in part to a "collision of complexity and immediacy."

—

Reading roundup: A few other stories and pieces to get to from the past holiday week:

— WikiLeaks began releasing its 2.4 million Syria-related emails last week, and while it initially named the AP as one of its collaborators, the AP was removed from the collaborator list and insisted it didn't collaborate with WikiLeaks, Buy Cipro No Prescription. The Atlantic's Alexander Abad-Santos questioned how everyone was going to sort through all the documents, and elsewhere, Buy Cipro no prescription, Agence France-Presse explored whether the U.S. has a case against WikiLeaks' Julian Assange.

— The Lab's Justin Ellis wrote an interesting piece looking at The New York Times' new Chinese-language site, but the project's already faced a setback, as its account on the Chinese Twitter-like site Sina Weibo has been shut down.

— Finally, a few cool articles worth reading this weekend: Here at the Lab, Ken Doctor wrote about aggregation apps like Pulse and the way metrics and subscription plans translate into money, and former GOOD magazine editor Ann Friedman offered some wise advice to young journalists and j-school grads. And tech blogger Erick Schonfeld argued that infographics are broken and proposed an alternative way of creating them.

August 27th, 2012

Tramadol Price

[This review was originally posted at the Nieman Journalism Lab Tramadol Price, on June 29, 2012.]

News Corp. undertakes historic split: In a move that's been predicted for at least a year or two, News Corp. took a drastic step this week to try to contain the damage from its phone hacking/bribery scandal by splitting its news and entertainment properties into separate companies. Its news company will include all of its newspapers in Britain, the U.S., and Australia as well as its Dow Jones newswire and HarperCollins book publishing; the entertainment company will include 20th Century Fox, the Fox TV channel, Tramadol trusted pharmacy reviews, Fox News, other cable channels, and BSkyB and other satellite TV properties. The Murdoch family will retain about a 40% share in both companies.

Wall Street loved the idea, with News Corp.'s shares jumping at the news that the company was discussing a split, Tramadol Price. The reason, as The New York Times' Dealbook explained, Tramadol cost, is that it could free News Corp. from what's known as the "Murdoch discount" — the depressed value of the company because of Rupert Murdoch's influence. Splitting news and entertainment, the thinking goes, frees entertainment to make more money without being weighed down by the newspaper division.

That, said Ryan Chittum of the Columbia Journalism Review, might harm the newspapers just as it helps the entertainment properties, Tramadol pics. Tramadol Price, The Guardian's Michael Wolff contended that the newspapers will lose the upside of being tied to the entertainment side, but keep the downside of being tied to Murdoch. As Reuters' Felix Salmon put it, "Up until now, Murdoch has never really needed to worry very much about his newspapers’ profitability, because the rest of his empire was throwing off such enormous profits. That’s going to change." According to Ad Age, though, What is Tramadol, News Corp.'s papers might do better on Wall Street than many others.

Murdoch said the split wasn't related to the phone hacking scandal, but pretty much everyone else found that claim preposterous. As Paul Sawers of The Next Web put it, the cracks from the scandal had spread too far. More specifically, according to the Guardian's Roy Greenslade, this allows News Corp, Tramadol Price. to invest in the properties it finds profitable (entertainment/BSkyB), and dump the liabilities (British newspapers). Here at the Lab, Tramadol dangers, Ken Doctor said the split will work out quite well for the Murdochs — investors will be happier, and Rupert can still play newspaperman while clearing the way for further entertainment domination.

As for what the move means more specifically, paidContent's Staci Kramer has a good rundown of what it means for each division, and she and the Guardian also looked at who might head up each company. Mathew Ingram of GigaOM urged News Corp. to let the content flow freely across platforms, Taking Tramadol, though Murdoch said his newspapers would be pushed even harder to charge for news online.

—

A Supreme breaking news error Tramadol Price, : The U.S. Supreme Court's ruling on the Affordable Care Act on Thursday was the occasion for one of the biggest media gaffes of the year, as CNN and Fox News both initially reported erroneously that the act's individual mandate had been found unconstitutional. Both networks issued statements, though only CNN — whose mistake was more prominently displayed and took longer to correct — could be construed as apologizing. Fox claimed it "reported the facts, as they came in," a statement with which both Poynter's Andrew Beaujon and the Washington Post's Erik Wemple took issue, order Tramadol from mexican pharmacy. (Wemple also objected to CNN's explanation of its error.)

The reaction against CNN in particular was quick and relentless: AP reporters were even ordered to stop taunting via social media. Within CNN, as well, the error was anonymously described to BuzzFeed as "shameful," "outrageous," and "humiliating." Rem Rieder of the American Journalism Review said it was a terribly timed stumble for the struggling CNN, and Wemple admonished, "Someone needs to tell CNN: There is no such thing as fashioning a scoop over something that’s released to the public."

Others put the blame within a broader context: The Huffington Post's Jason Linkins described it as a "There but for the grace of God go I" situation for journalists, and the American Copy Editors Society's Charles Apple called it the product of a too-fast media cycle meeting the constantly changing nature of breaking news, Tramadol Price.

Other news orgs reinforced that emphasis on speed: A Washington Post profile on SCOTUSblog, the top destination for instance Supreme Court analysis, noted the site's obsession with getting the news first. Meanwhile, mainstream news orgs fought over who broke the story first (Andrew Beaujon's answer: it depends), Tramadol coupon, and Rem Rieder said that issue is not only unimportant, but harmful to good journalism.

—

Flipboard and Pulse's models compete for publishers: The New York Times extended its online pay plan this week to include the aggregation app Flipboard, allowing subscribers to access all the Times content there, while limiting nonsubscribers' access to a few free articles. At All Things D, Peter Kafka pointed out that this is the first time the Flipboard has gotten a major publisher to give it full access to its content there, as well as the first time the Times has given out full access to its content through another platform, get Tramadol. Tramadol Price, Kafka also wondered if Flipboard access is really going to add much for Times subscribers, since they already have access to the Times on just about any device they could want. On the other hand, GigaOM's Mathew Ingram liked the idea as a way to acknowledge new ways users are getting news while maintaining control over the pay plan. Jeff Sonderman of Poynter had a few notes for other news orgs, pointing out the Times' statistic that 20% of its readers use aggregation apps and suggesting that this might be a good option for smaller news orgs that can't afford their own extensive app development. And TechCrunch's Alexia Tsotsis weighed in with an angry, drunk anti-Times post. Tramadol natural, At the same time, though, Conde Nast's Wired and The New Yorker announced they're stepping back from Flipboard, giving up selling ads and pulling most of their content. Publishers told Mashable's Lauren Indvik it's just easier (andm more profitable) to sell ads on their site once Flipboard takes its cut, and paidContent's Jeff John Roberts said Flipboard may need to reconsider its revenue-sharing arrangement with publishers, Tramadol Price.

In addition, a day after the Times announced its Flipboard pay plan, the Wall Street Journal announced a similar plan with one of Flipboard's competitors, Pulse, where to buy Tramadol. The Journal's move was part of a strategy shift by Pulse toward paid subscriptions that the company expects to launch it into profitability. Ingram of GigaOM compared Pulse's subscription-based model (which involves subscription revenue sharing and Flipboard's ad-based model — though both are "competing with their publishing clients even as they try to serve them."

—

Is BuzzFeed stealing ideas?: BuzzFeed, one of the most popular viral content sites on the web, got some scrutiny this week that raised questions in the ongoing discussion about the validity of online aggregation practices. Slate's Farhad Manjoo looked behind the curtain at where BuzzFeed gets the material for its most popular viral posts and found they mostly come from Reddit, with attribution (possibly systematically) stripped. Philip Bump of Grist said Manjoo didn't go far enough Tramadol Price, in his critique, saying that BuzzFeed isn't just aggregating but stealing ideas. Tramadol recreational, But The Atlantic's Derek Thompson pushed back against the BuzzFeed criticism, comparing their raiding Reddit to movie studios grabbing ideas from bestselling books. "BuzzFeed is a hit-maker making hits the only way reliable hits can be made: By figuring out what's already popular and tweaking them to make something new," he wrote.

—

Reading roundup: A few other smaller stories going on in the background this week:

— Google formally unveiled a number of new products at a press event this week — a streaming media device called the Nexus Q (powered by other Android devices on the same network); a $199 tablet called the Nexus 7; its much-anticipated augmented-reality glasses, Google Glass; and a tablet app for Google+, among a few other things. For some analysis, here's All Things D on the Nexus Q and Google Glass, Tramadol over the counter.

— This week in paywalls: The Chicago Tribune's redesigned website will require registration for some content, a mechanism designed to transition to paid subscriptions. (It's also including some content from the Economist and Forbes in that plan.) U-T San Diego also launched a metered pay plan, and The New York Times will begin charging for crossword puzzles even outside of its subscriptions. Tramadol no rx, Meanwhile, Gannett said its circulation is down but revenue is up at its paywalled papers, and Steve Outing argued against the metered model.

— Two thought-provoking pieces on reinventing journalism, from different perspectives: The Online Journalism Review's Robert Niles on how to reboot newspapers by breaking up the chains, and Technology Review's Christopher Mims on the red flags in many proposals to reinvent journalism (abandoning the news story, lack of knowledge of the business model, vagueness about the medium), after Tramadol.

— Finally, some great pieces here at the Lab this week: An interesting post by Jonathan Stray on how our perception plays into news bias, Clay Shirky on the importance of Gawker's innovation in commenting, and Adrienne LaFrance's illuminating postmortem on The New York Times' involvement with NYU's The Local.

August 27th, 2012

Glucophage Dosage

[This review was originally posted at the Nieman Journalism Lab Glucophage Dosage, on June 22, 2012.]

Microsoft's unknown but intriguing tablet: Yet another company made its jump into the tablet market this week, but this was a more formidable competitor than most: Microsoft unveiled its new Surface tablet PC with precious little information, though the keyboard-cover and Windows 8 operating system got some critics' attention. Reaction from analysts was generally mixed (you can see a good variety at Engadget and the Guardian) — many were intrigued and encouraged by what they saw so far, but wanted to know more before they formed a verdict.

The big question for many observers was whether Surface might finally present a legitimate competitor for the iPad. Reuters talked to experts who said it's too soon to tell (especially since we don't know its price yet), and The New York Times' David Pogue argued that Microsoft has an uphill battle to fight, particularly because of how far behind Apple it's starting. Order Glucophage online c.o.d, The Times' Sam Grobart, however, said Microsoft may be gunning more for the ultra-light notebook computing market than the touch-screen tablet market.

Mat Honan of Gizmodo said Surface's keyboard will be the key to challenging the iPad and Macbook Air's dominance in those areas, and Dutch entrepreneur Max Huijgen asserted that the keyboard finally moves tablets from consumption to creation devices, Glucophage Dosage. The Verge's Joshua Topolsky said Surface could fit perfectly between the iPad and the laptop, but it'll depend on price and how many developers they can get to create apps for it.

Several others noted that this week's announcement marked a significant shift for Microsoft — from software developer to hardware producer. Microsoft has ventured into hardware before (most notably with its mp3 player Zune), but as All Things D's Ina Fried pointed out, buy generic Glucophage, this is a much more important venture. Slate's Farhad Manjoo argued that the Surface seems to be a much more thought-out venture into hardware than the Zune. He and Dan Frommer Glucophage Dosage, of SplatF were excited that Microsoft is finally taking quality hardware into its own hands, as Frommer said: "it sure looks like a better strategy for Microsoft than only trusting the Samsungs of the world to design great Windows tablets, and only trying to generate mobile revenue from Windows sales."

Meanwhile, the Columbia Journalism Review's Ryan Chittum took the opportunity to chastise the tech press for its fawning coverage of product announcements, saying they're acting more like an infomercial audience than journalists.

—

Blogging, big ideas, and 'self-plagiarism': One of nonfiction writing's young stars was discovered to be repeatedly reusing his own work this week, raising some questions about the relationship between journalism, Glucophage blogs, blogging, and trading in "big ideas." Jonah Lehrer, who was recently hired by The New Yorker, was discovered to have borrowed much of the material for his first several New Yorker blog posts from earlier pieces. Jim Romenesko first uncovered the repetition in one post, and it was quickly found in each of his others, as New York magazine documented.

Edward Champion of Reluctant Habits soon found several re-used passages in Lehrer's most recent book, is Glucophage addictive, and more serious issues cropped up as well: Romenesko and Poynter's Andrew Beaujon noted cases in which Lehrer had made it sound like he had gathered information directly when they had in fact come from secondhand sources. All of Lehrer's New Yorker posts now contain editor's notes, and Lehrer has apologized. While his editor at The New Yorker said he "understands he made a serious mistake," it appears he won't be fired.

Much of the discussion around Lehrer centered on just how serious of a mistake he had made, and why it might have happened, Glucophage Dosage. Gawker's Hamilton Nolan argued that even if he's not cheating himself with his copying, he's cheating his employer, Rx free Glucophage, who's not paying him to recycle old material. Jack Shafer of Reuters made a similar point, but noted that certain types of republication are a pretty established part of journalistic practice. Poynter's Kelly McBride talked about how the practice cheats the audience.

As for why Lehrer might have done this, Gawker's Nolan concluded that Lehrer simply "doesn't know how to do journalism" and said that while he might consider himself just a purveyor of ideas, The New Yorker is very much a journalistic publication. Slate's Josh Levin posited that Lehrer's "big ideas" stock and trade isn't compatible with blogging Glucophage Dosage, , because while big ideas are rare and have to be wrung dry, blogging requires constant streams of fresh insight. At the Columbia Journalism Review, herbal Glucophage, Felix Salmon said "big ideas" blogging can indeed be done — by iterating ideas, using links as shorthand, riffing on what you're reading, and interacting with peers.

Others objected to the term "self-plagiarism" to describe what Lehrer did — the Washington Post's Erik Wemple, Reuters' Shafer, Glucophage photos, and the New York Times' Phil Corbett, via Poynter. And Poynter's Craig Silverman pointed out how catching plagiarists (or serial repeaters) has become something of a game in itself.

—

Debating the value of print in New Orleans: The aftermath of the New Orleans Times-Picayune's cuts continued this week, as the paper published another optimistic message to readers about its future, this one from its publisher, Ricky Mathews. Ryan Chittum of the Columbia Journalism Review criticized Mathews for not mentioning the paper's massive layoffs, and Poynter's Steve Myers reported on the efforts of readers and advertisers to provide for laid-off reporters and convince Advance to rethink its print cuts, Glucophage Dosage.

Poynter's Rick Edmonds agreed with those readers and former staffers, fast shipping Glucophage, breaking down the numbers and arguing that there isn't much of a business case for cutting print editions of the paper. Instead, he said, "The move only makes financial sense as the occasion for dumping many well-paid veterans and drastically slashing news investment" — which is how the paper appears to be using it.

The University of Colorado's Steve Outing defended the decision to cut print editions, arguing that an investment into mobile media by the TP could keep readers just as informed as with a seven-day print edition. Online Glucophage without a prescription, Poynter adjunct Jason Fry came down in the middle, saying that while he's not opposed to cutting print in general, New Orleans is the wrong place — and Advance's strategy the wrong way — to do it.

—

Glucophage Dosage, Two paywalls up, one down: News organizations (and newspapers in particular) continue to put up paywalls at a steady pace — this week, we got an announcement from one of Australia's largest newspaper companies, Fairfax Media, that it would put up a paywall and cut 1,900 jobs at its publications, two of which, the Sydney Morning Herald and The Age, will merge newsrooms. Poynter's Andrew Beaujon summarized the situation, and former Age editor Andrew Jaspan explained Fairfax's decline and sounded a warning regarding the concentration of Australian media in the hands of a few moguls.

Warren Buffett's longest-held newspaper, The Buffalo News, also announced plans for a paywall, Glucophage overnight. Beaujon has the details, and The New York Times' Christine Haughney examined the News for clues to Buffett's style of newspaper management. Elsewhere, however, the New York Post (a Rupert Murdoch paper) dropped the pay plan for its iPad version, and the Online Journalism Review's Robert Niles made the case against paywalls and urged newspapers to focus solely on the unique value they can provide.

—

A new set of news innovators: The Knight Foundation announced the winners of the first round of this year's Knight News Challenge, the first year of its new three-times-a-year incarnation, Glucophage Dosage. About Glucophage, Here are the six winners, all based on the theme of networks: Behavio, a collective mobile data-sharing service (Lab profile, Techcrunch profile); PeepolTV, a livestreamed video collection project; Recovers.org, a disaster recovery organization (Lab profile); Tor Project, an open-source anonymity-aiding initiative (Lab profile); Signalnoi.se, a tool to help newsrooms understand how information moves through social networks (Lab profile, Glucophage pharmacy, Journalism.co.uk profile); and Watchup, a video news iPad app (Lab profile).

Mathew Ingram of GigaOM saw in the winners the importance of mobile media, video, and large-scale data collection, while the Lab's Joshua Benton said he feels the overall quality of applications was up this year. Buy Glucophage without a prescription, The foundation also announced the creation of the Knight Prototype Fund, which is intended as a smaller-scale, quicker way of funding innovative news projects. The Lab's Justin Ellis profiled the fund, while the MIT Center for Civic Media published an interview with two of its principals.

—

Reading roundup: Here are the other stories folks in the news-tech world were talking about this week:

— The New York Times announced a partnership Glucophage Dosage, with BuzzFeed to collaborate on coverage of this year's political conventions, particularly through video. The Washington Post's Erik Wemple looked at what it means for the Times and BuzzFeed, and The Atlantic's Megan Garber said you can expect BuzzFeed's lolcattiest tendencies to be toned down.

— WikiLeaks' Julian Assange sought asylum in the Ecuadorian embassy in London as an attempt to avoid extradition to Sweden on sex crime accusations, Glucophage gel, ointment, cream, pill, spray, continuous-release, extended-release. Doing so was apparently a breach of his bail terms, but Salon's Glenn Greenwald defended Assange's right to seek asylum. Former WikiLeaks staffer James Ball looked at where things currently stand with the Assange drama.

— Information Architects' Oliver Reichenstein proposed a strikethrough "mark as error" function on Twitter as an alternative to deleting erroneous tweets, Glucophage Dosage. Poynter's Craig Silverman and GigaOM's Mathew Ingram voiced their support for the idea, and Journalism.co.uk asked editors for their thoughts on it. Twitter, Glucophage pictures, meanwhile, did introduce an option to view profiles without replies.

— In the most recent of several thoughtful pieces on how to improve journalism education that have been published lately, Howard Finberg advised j-schools to look to large-scale, online education to train tomorrow's journalists, and j-prof Jeff Jarvis sketched a few ideas for such a plan. J-prof Carrie Brown-Smith did counter, however, that j-schools' current skills education has value because an alarming number of students come in with such poor grasp of basic skills.

— Finally, two smart pieces to read this weekend: Here at the Lab, Jonathan Stray wrote about the inherent difficulties in designing filtering algorithms, and at Poynter, PolitiFact's Bill Adair urged journalists to supplant the news story as the basic form of journalism.

August 27th, 2012

Synthroid Mg

[This review was originally posted at the Nieman Journalism Lab Synthroid Mg, on June 15, 2012.]

Since there was no review last week, this review is covering two weeks.

Big cuts in the Big Easy: Three weeks after news of the New Orleans Times-Picayune's cutback to three-day-a-week publication broke, the other shoe dropped this week, as Advance Publications laid off about 200 of the paper's employees, including almost half the newsroom. About 400 employees at Advance's Alabama papers were let go, too, making it one of the largest rounds of layoffs in recent American newspaper history. Poynter's Steve Myers has a great link-filled survey of the carnage, online buying Synthroid hcl, while The New York Times' Campbell Robertson portrayed the scene in New Orleans.

The people of New Orleans were, needless to say, not pleased, and they expressed their disapproval of Advance in a variety of ways. A group of major local businesses and civic organizations formed to try to stop the changes to the paper, Synthroid forum, and several major TP advertisers signed on. A "Save Our Picayune" rally drew hundreds, and the nonprofit New Orleans news org The Lens captured the deep connection between the city's residents and its paper in a photo essay, while Poynter's Julie Moos examined the story behind it, Synthroid Mg.

Advance responded to the protests by saying it wouldn't back down from its plans and publishing a thoughtful column on the roots of the paper's changes, but it was also facing criticism from outside the city as well. The American Journalism Review's Rem Rieder criticized Advance for burying the news of its layoffs while trumpeting a positive video to readers about their coming changes. Jason Berry of The Nation gathered a variety of expert opinions, including "This is a breathtaking gamble" and “This is one of the dumbest decisions by any newspaper publisher ever."

Advance is modeling the online transition of the TP and its Alabama papers after its former newspaper in Ann Arbor, Michigan, a decision that has brought quite a bit of disdain, order Synthroid no prescription. Mary Morgan, publisher of another online news org in that city, the Ann Arbor Chronicle, described what she saw as a superficial approach to its community. Synthroid Mg, At the Atlantic, John McQuaid said Advance's online strategy is more focused on gathering clicks than doing comprehensive journalism, and at the Columbia Journalism Review, New Orleanian Harry Shearer said Advance is taking a cookie-cutter approach to journalism. Fortune's Dan Mitchell agreed, saying, Japan, craiglist, ebay, overseas, paypal, "Advance's decision isn't an investment in the digital future -- it's simply proof that Advance wants to squeeze every nickel it can out of the operation as quickly as possible." CJR's Ryan Chittum made a similar point, expressing his disappointment that the paper is gutting its newsroom and moving to a "hamster-wheel" approach online.

The Lab's Adrienne LaFrance looked to a different model — Detroit, whose two newspapers cut daily delivery down to three days a week in 2009. She looked at the differences between the two cities and also addressed the possibility that people simply won't miss the print paper.

—

The futures of print and paywalls: The discussion about the Times-Picayune also bled into a couple of bigger debates about where the news industry is (or should be) headed. The largest one focused on what role print media should have in newspapers' future, as both the New York Times and American Journalism Review ran features focusing on the potential benefits and dangers for newspapers in moving to a digital-centric approach, Synthroid Mg. The Times looked in particular at the hamster-wheel effect of chasing pageviews in a digital-first context, while AJR looked at the possible importance of targeting niches and experimenting with different models, Synthroid cost.

GigaOM's Mathew Ingram argued that doing digital journalism makes news organizations just another voice and doing it well costs lots of money, so if you're shifting primarily as a cost-cutting move (as Advance seems to be), you shouldn't expect to retain your authoritative voice. The Guardian's Roy Greenslade disagreed about the nature of authority online, but agreed that publishers are seeing the move to digital as a cost-cutting measure rather than a way to aggressively move journalism forward.

Reuters' Jack Shafer put the issue in a different way, Where can i buy Synthroid online, describing newspapers "liquidating their goodwill" — by raising prices, cutting delivery days, and shedding reporting costs — as a way of trying to extract money out of their properties before their useful life is up. Synthroid Mg, The news execs cheapening their products might protest that they're still pouring investment into their papers, Shafer said, but "if you’re winding your company down with no strategy to wind it up, you’re burning goodwill even if you don’t acknowledge it." Ingram seized on that point and urged newspaper execs to have a real plan for digital reinvention.

The other debate that flowed out of the mess in New Orleans regarded paywalls, stemming from David Simon's May Columbia Journalism Review post arguing that failures like the Times-Picayune's will continue occurring until newspapers start charging for online content. Poynter's Andrew Beaujon gave some highlights of the long discussion in the comments of that piece, and The Batavian's Howard Owens responded with a comprehensive CJR post of his own listing 10 arguments against news paywalls. CJR blogger Ryan Chittum took up Simon's cause, Synthroid coupon, issuing a response to each of Owens' points. At the Harvard Business Review, Justin Fox said it really doesn't matter what Advance and other newspapers do — the industry has been doomed for a while, and Advance is just trying to get out in front of the collapse.

—

Apple and Facebook vs, Synthroid Mg. Google: Apple held another product release announcement this week, and, Buying Synthroid online over the counter, as usual, the tech press went ga-ga over it. If you're an Apple geek, you probably already know all the details, but if you want to gorge yourself on specs, features, and screenshots, Techmeme has everything you need, buy generic Synthroid. The big new product was Apple's iOS 6, the new platform on which the iPhone, iPad, and iPod will eventually run. TechCrunch has a good rundown of its features, as well as a few quick thoughts. Synthroid Mg, As part of its announcement, Apple introduced a new laptop, gave an update on its new desktop operating system Mountain Lion, and unveiled an iOS 6 feature called Passbook that integrates all kinds of passes and tickets. Synthroid australia, uk, us, usa, (It did not, however, open up Apple TV to outside developers, as some had expected.)

One particularly interesting announcement was the deep integration of Facebook into iOS 6, including quick sharing, Siri integration, and sharing from the App Store and Game Center. Josh Constine of TechCrunch said Apple seems to be borrowing Facebook's social graph rather than trying to do social tech itself, Synthroid interactions, and The Next Web's Drew Olanoff said Apple's new side-by-side display of Facebook and Twitter functions could lead users to see Facebook as the superior network. CNET's Larry Dignan, on the other hand, saw the Facebook integration as an oversharing nightmare waiting to happen.

There were relatively few big-picture reflections on the announcements: Tech blogger John Gruber saw an anti-Google tint to the proceedings, and Business Insider laid out the ways Apple is going after Google's products and "trying to make the web irrelevant." And here at the Lab, Online Synthroid without a prescription, Josh Benton had a few takeaways for news orgs, including advice to prepare for people to expect to talk to your app and the use of Passbook for news org membership models.

—

Making curation count: A little update on the ongoing conversation surrounding online curation and aggregation of content: It flared up a couple of weeks ago after a speaker was quoted as saying that curation was "replacing creation as a form of self-expression." That set off The Awl's Choire Sicha, who said curation was an awful, arrogant word for something that's actually just collecting other people's creative work as part of a secondary market, Synthroid Mg. Editor Erin Kissane and Pocket's Mark Armstrong both defended the practice of curation (if not the term itself) and advised a collaborative approach to improving it as a technique and as a business model.

Poynter's Andrew Beaujon summarized the discussion, tying it to a satirical post by the Washington Post's Michael Cavna. On the practical level, the Lab's Justin Ellis described how one curator, Dan Shanoff, Synthroid pictures, was able to turn his hand-picked sports aggregation site Quickish into something valuable (it was bought this week by Gannett), and Digital First Media's Steve Buttry and Mandy Jenkins outlined their vision for the news curation team they're hiring.

—

Reading roundup: Bunches of smaller stories and and discussions bubbling up over the past couple of weeks. Synthroid Mg, Here's a quick summary:

— In a significant case for the TV and online video industries, the U.S. Department of Justice is investigating several cable companies for possible antitrust violations in limiting online video use by the broadband Internet customers as a way to keep people from cutting the cord on cable. The story was first reported by the Wall Street Journal, and Mike Masnick of Techdirt laid out the government's case, Buy Synthroid online cod, which he says is a good one. Fortune, GigaOM and All Things D have analyses of what this might mean for consumers. In a related development, YouTube's head talked about the possibility of selling paid subscriptions to its videos.

— The social activism-focused magazine GOOD, launched in 2006, laid off most of its staff two weeks ago. The publication's executives reportedly wanted to become "a Reddit for social good," though they denied that characterization, Synthroid Mg. The laid-off staffers are going to produce one last magazine issue together, Synthroid natural, and they're calling it Tomorrow. Poynter's Andrew Beaujon and The Atlantic's Alexander Abad-Santos have good postmortems on what went wrong at GOOD.

— The Chicago Tribune reported that its owner, the Tribune Co., is close to emerging from bankruptcy after three and a half years there, and Ad Age reported that the company would probably sell some of its major assets, including the Tribune and the Los Angeles Times. Reuters' Jack Shafer looked at the possible futures of the Tribune Co.'s papers, and it wasn't pretty. Synthroid Mg, — Warren Buffett continues to dive deeper into the newspaper industry, buying up a 3.2% stake in the Lee Enterprises newspaper chain as well as a small daily paper in Texas. Buffett explained his strategy to Howard Kurtz of The Daily Beast, and Andrew Beaujon of Poynter pitted that strategy against Advance's web-based one.

— AOL survived a fight from some of its major investors who believe that the hyperlocal journalism model they've pursued with Patch is a fatally flawed one, as Bloomberg Businessweek's Felix Gillette outlined. AOL had some positive numbers to throw at them this week, as Patch has posted its best traffic numbers ever.

— Finally, a couple of the many thought-provoking pieces posted over the past couple of weeks: The Lab's Adrienne LaFrance examined newsrooms' attitude toward innovation through the lens of the hypothetical (or maybe not so hypothetical!) "smart refrigerator strategy." And Arizona State j-prof Tim McGuire delivered his manifesto on the state of journalism and what news organizations should and shouldn't be doing in a rapidly changing media environment.

June 1st, 2012

Order Synthroid

[This review was originally posted at the Nieman Journalism Lab Order Synthroid, on June 1, 2012.]

Debating the meaning of Facebook’s IPO flop: Facebook’s fall following its initial public offering two weeks ago continued this week, with shares dropping under $30 (they were initially offered at $38). Several other social media-based companies have seen their stock tank, too, prompting Forbes’ Dee Gill to wonder if Facebook’s IPO has been a reminder that “even a wildly popular product won’t save a company that can’t make money.”

David Strom of ReadWriteWeb did point out, though, that stock prices soon after tech IPOs haven’t been a very reliable indicator of companies’ prospects for long-term success. The New York Times’ Joe Nocera made a similar point, arguing that Facebook’s IPO flop was fueled by get-rich-quick investors and that long-term investors should be undeterred, Synthroid treatment.

At PandoDaily, Farhad Manjoo made the case that Facebook’s IPO was a valuable corrective to a dangerously overhyped tech market: “Facebook’s IPO proves that there isn’t an endless supply of bigger suckers. And because bigger suckers are the primary ingredients in bubbles, it now seems likely that the new tech bubble—if there ever was one—is dead, dead, dead.” And The Atlantic’s Alexis Madrigal made a pretty thorough defense of Facebook’s value as a company, Synthroid forum, reminding us that it has a still-growing near-monopoly and tremendous potential for making money from its millions of users.

There was still plenty of criticism of Facebook floating around this week, though, Order Synthroid. The New York Times’ Ross Douthat saw Facebook as a sign of the lack of financial progress brought by the Internet economy, and Facebook’s advertising shortcomings continued to be a point of discussion. Ad Age reported that GM pulled its advertising from Facebook in part because Facebook balked at its proposal to run full-page ads, which, according to media consultant Terry Heaton, illustrated the difference between Madison Avenue’s philosophy of bending the masses to their will and Facebook’s gentler approach. The Huffington Post’s Bianca Bosker also looked at the tension Facebook is facing between its advertisers and users, Synthroid maximum dosage.

Here at the Lab, Dan Kennedy extended the ad problem to journalists, proposing a few ideas for adapting to an online world in which the value of ads continues to shrink. Order Synthroid, Also on the news front, Buzzfeed’s John Herrman wrote about how coverage on Twitter of the Facebook IPO indicates that Twitter is well ahead of Facebook in covering and developing breaking stories.

Another major note on Facebook to keep an eye on: The New York Timesreported that the company is trying again to build a smartphone to release later this year. It’s had several false starts in this area before, but is moving “deeper into the process” this time. Is Synthroid addictive, Facebook was also reported this week to be buying the facial recognition company Face.com.

—

The impact of New Orleans’ move away from print: As we moved into the second week of discussion of the New Orleans Times-Picayune’s cutback from daily newspaper production, the conversation began to shift from New Orleans in particular to the future of the newspaper industry as a whole. Poynter’s Steve Myers looked at a couple of the immediate issues — concerns over whether Advance Publications’ other papers (such as the Cleveland Plain Dealer) might make similar cuts, and whether New Orleans readers are likely to follow their paper online, Order Synthroid.

The New York Times’ David Carr, who broke the story, wrote a kind of elegy for the paper, concluding that while the cutback may make some financial sense, it’s a great loss for a historically corrupt city. “The constancy of a paper, ordering Synthroid online,” he wrote, “is a reminder to a city that someone is out there watching.” At the Huffington Post, Harry Shearer thought Carr wasn’t harsh enough in his assessment of Advance’s plans, arguing that breaking readers’ daily newspaper habits is foolish, not economical. Shearer, Synthroid wiki, Myers, and Iowa journalist Dave Schwartz all pointed out that New Orleans has particularly low Internet penetration rates (not to mention high newspaper penetration rates), with Schwartz calling those without web access “casualties in a revolution.”

Mathew Ingram of GigaOM and CUNY prof Jeff Jarvis, on the other hand, both argued that we need to get past our fixation with print journalism, using it when it’s profitable but feeling free to drop it when it’s not. “We have to make print beside the point,” Jarvis wrote, Synthroid without prescription. Will Bunch of the Philadelphia Daily News, meanwhile, proposed some ideas at Poynter for resolving the journalism crisis in New Orleans, focusing on philanthropic efforts to improve Internet access, hyperlocal journalism, and accountability journalism. Al Jazeera discussed the future of the newspaper industry Order Synthroid, in light of New Orleans’ move away from daily with a few luminaries as well. Synthroid dangers,

—

Cuts, layoffs, and the viability of paywalls: The Times-Picayune isn’t the only paper making these kinds of changes — Postmedia, Canada’s largest newspaper chain, announced this week it would cut the Sunday edition at three of Canada’s largest newspapers, lay off dozens of employees, and consolidate some of its editing operations, and also hinted at cutting back print days for its largest paper, Synthroid images, the National Post. Postmedia was also reported to be moving ahead with paywalls at several of its papers.

While Postmedia CEO Paul Godfrey complained in an interview with the Globe & Mail that its ad revenue was being stolen by foreign digital companies (read: Google, AOL, etc.), GigaOM’s Mathew Ingram said the problems for Postmedia and other newspapers run much deeper than cuts and paywalls. Synthroid street price, Crain’s Chicago Business also reported that the Chicago Tribune is considering a paywall potentially focusing on niche coverage, and Poynter’s Steve Myers pointed out that the major newspaper companies that aren’t charging for news are quickly becoming the outliers.

The paywall debate got a shot in the arm this week in the aftermath of the Times-Picayune’s cuts, when The Wire creator and former newspaper reporter David Simon asserted at the Columbia Journalism Review that “the whole industry will continue to collapse until everyone swallows hard and goes behind a paywall.”The short post spurred a feisty comment thread as well as several varying responses, Order Synthroid. A post at the news startup Circa made a distinction between charging for content (OK) and information (much more difficult to do), and Will Bunch made his aforementioned philanthropically driven proposals for New Orleans as a middle way between paywall advocates and detractors.

In addition, former newspaper editor John L. Robinson argued that if young people won’t even pay much for Facebook, they sure won’t pay for a newspaper — and that should worry newspaper publishers, Synthroid class. Here at the Lab, Ken Doctor added some practical approaches to the discussion, looking at the effectiveness of different newspapers’ plans to shift from advertiser revenue toward reader revenue.

—

Breaking down the article Order Synthroid, : We got a reprise of the occasionally occurring discussion about better ways to do the news article this week, starting with NYU professor Jay Rosen’s complaint that a Reuters article on Facebook’s IPO was too dense for non-investors to understand. That triggered a lengthy Twitter conversation between Rosen, Reuters’ Anthony De Rosa and Felix Salmon, and CUNY professor Jeff Jarvis — Storified by De Rosa — about ways to better incorporate background information into news stories. Synthroid trusted pharmacy reviews, Rosen has done plenty of thinking about this problem in the past, and this time, Jarvis expanded the Twitter discussion into a post of his own in which he reconceived the news article as a group of assets (data, background information, leads, etc.) that could be broken down, rearranged, or specialized in by various news organizations, order Synthroid from United States pharmacy, with links as the core element tying them together. “The end result is still an inverted pyramid — a prioritized set of assets that one can stop going through when one feels sated with information. But everyone’s pyramid can be different. And what fills those pyramids can come from various sources,”he wrote.

Mathew Ingram of GigaOM echoed the idea, and meanwhile, Technically Philly’s Sean Blanda and blogger Dave Winer both wrote on rethinking the elements of an article — Blanda proposed thinking of the basic unit of journalism as the fact rather than the article, and Winer said we need to do better than Wikipedia when it comes to background information and explainers, Order Synthroid.

—

Reading roundup: Lots of little stories and debates popping up at the intersection of news and tech this week. Here’s a few of them:

— WikiLeaks’ Julian Assange lost his appeal to the British Supreme Court against extradition to Sweden on accusations of a pair of 2010 sexual abuse cases. No prescription Synthroid online, He has two weeks to appeal one of the ruling’s points, but it looks as though he’s headed to Sweden to stand trial. Here’s The Guardian’s and The New York Times’ coverage, and Micah Sifry’s examination of the state of online whistleblowing as WikiLeaks struggles.

— A couple of ebook notes: Amazon settled its dispute Order Synthroid, with a publisher that pulled its books from the site earlier this year, and meanwhile, two other publishers filed responses to the Department of Justice’s antitrust suit on ebook pricing, and Apple filed its response to a parallel class-action suit.

— Web designer Oliver Reichenstein ripped the ubiquitous “Share” buttons all over news and other sites, while the Lab’s Joshua Benton provided some initial data showing they may be quite helpful for news orgs to prompt sharing of their content on Twitter.

— Cornell prof Tarleton Gillespie wrote an interesting post exploring whether we can trust Twitter’s Trending Topics algorithm, and GigaOM’s Mathew Ingram said it’s not necessarily Twitter’s job to broaden our worldview, Synthroid dose, but instead our own responsibility.

— Some additional commentary on Warren Buffett’s purchase of dozens of small Media General papers two weeks ago: NYU prof Clay Shirky thinks it’s a bad idea, and Mathew Ingram agrees with him.

— Finally, it’s not shameless self-promotion if it’s actually really good: The Lab ran several fascinating pieces this week that are worth a look — Justin Ellis’ talk with Guardian editor Alan Rusbridger, some cool ideas for improving news from MIT Media Lab students courtesy of Andrew Phelps, and the AP’s Jonathan Stray’s smart column on broadening our concept of what journalists do. Enjoy.

Mark Coddington

Associate Professor, Washington and Lee University

this week

Buy Cipro No Prescription

Tramadol Price

Glucophage Dosage

Synthroid Mg

Order Synthroid